Announcements Trials
Browse Landscape

Phase

Phase 3 4Phase 2 4Phase NA 3Phase 4 1

Status

Completed 16Active not recruiting 10Unknown 4Recruiting 3Terminated 2

Sponsor Class

OTHER 2NIH 1NETWORK 1

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 3Head & Neck 1

Conditions

Prostatic Neoplasms 3Salivary Gland Adenoma, Pleomorphic 1

Interventions

Cisplatin 130Radiotherapy 94Carboplatin 85Paclitaxel 78Fluorouracil 78Cyclophosphamide 77Gemcitabine 72Capecitabine 66Docetaxel 65Doxorubicin 60Oxaliplatin 59Etoposide 57Leucovorin 49Vincristine 47Chemotherapy, Adjuvant 42Cytarabine 38Dexamethasone 35Drug Therapy 33Bevacizumab 30Epirubicin 29Neoadjuvant Therapy 28Pemetrexed 27Tamoxifen 25Prednisone 24Irinotecan 24Rituximab 21Methotrexate 21Radiotherapy, Intensity-Modulated 19apatinib 18Vinorelbine 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × Unknown × Gonadotropin-Releasing Hormone × Clear all
NCT00567580 2025-05-09

Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancer

Radiation Therapy Oncology Group

Phase 3 Unknown
1,792 enrolled 27 charts
Genitourinary

Prostatic Neoplasms

NCT00363285 2013-08-26

Cyproterone Acetate in Treating Patients With Newly Diagnosed Stage III or Stage IV Prostate Cancer

National Cancer Institute (NCI)

Phase 3 Unknown
900 enrolled
Genitourinary

Prostatic Neoplasms

NCT00175383 2013-04-11

Long Acting LHRH Versus Short Acting LHRH in the Treatment of Prostate Cancer

University of British Columbia

Phase 3 Unknown
100 enrolled
Genitourinary

Prostatic Neoplasms

NCT00764166 2008-10-01

RisingPSA

Assistance Publique - Hôpitaux de Paris

Phase 3 Unknown
254 enrolled
Head & Neck

Salivary Gland Adenoma, Pleomorphic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡